Cognitive function after systemic therapy for breast cancer

ONCOLOGY

Volumn 15, Issue 5, 2001, Pages 613-618

  Olin, Julie J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; BREAST TUMOR; CANADA; COGNITIVE DEFECT; FEMALE; FORECASTING; HUMAN; MIDDLE AGED; REVIEW; TREATMENT OUTCOME; UNITED STATES; WOMEN'S HEALTH;

ADULT; BREAST NEOPLASMS; CANADA; COGNITION DISORDERS; ESTROGENS; FEMALE; FORECASTING; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES; WOMEN'S HEALTH;

EID: 0035347785     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 51:15-36, 2001.
2. Ganz PA: Long-term complications after primary therapy of breast cancer, in Perry MC (ed): American Society of Clinical Oncology 2000 Educational Book, pp 393-399. Baltimore, Lippincott Williams & Wilkins, 2000.
3. Cognitive decline from adjuvant chemotherapy for breast cancer? Clinical Oncology Alert March 1, 1998.
4. Chemobrain: Chemotherapy side effect? Patient Perspectives pp 1-2, April 1996.
5. Prassopoulos P, Cavouras D, Evlogias N, et al: Brain atrophy in children undergoing systemic chemotherapy for extracranial solid tumors. Med Pediatr Onc 28:228-233, 1997.
6. Meyers CA, Weitzner M, Byrne K, et al: Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 12:820-826, 1994.
7. Ahles TA, Tope DM, Furstenberg C, et al: Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 14:1457-1462, 1996.
8. King DA, Caine ED, Conwell Y, et al: The neuropsychology of depression in the elderly: A comparative study of normal aging and Alzheimer's disease. J Neuropsychiatry Clin Neurosci 3:163-168, 1991.
9. Wieneke MH, Dienst ER: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61-66, 1995.
10. van Dam FS, Schagen SB, Muller MJ, et al: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218, 1998.
11. Schagen SB, van Dam FS, Muller MJ, et al: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650, 1999.
12. Brezden CA, Phillips KA, Abdolell M, et al: Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-2701, 2000.
13. Ahles TA, Silberfarb PM, Herndon J, et al: Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukemia Group B. J Clin Oncol 16:1954-1960, 1998.
14. Cull A, Hay C, Love SB, et al: What do patients mean when they complain of concentration and memory problems? Br J Cancer 74:1674-1679, 1996.
15. Faust D, Fogel BS: The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25-31, 1989.
16. Ahles TA, Saykin AJ: Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest. In press.
17. Ahles TA, Whedon MB: Chemobrain: Cognitive impact of systemic chemotherapy. Coping With Cancer p 48, July/August 1999.
18. Meyers CA: Neurocognitive dysfunction in cancer patients. Oncology 14:75-85, 2000.
19. Jacobsen PB, Stein K: Is fatigue a long-term side effect of breast cancer treatment? Cancer Control 6:256-264, 1999.
20. Yaffe K, Cauley J, Sands L, et al: Apolipo-protein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 54:1110-1114, 1997.
21. Barrett-Connor E, Krizt-Silverstein D: Estrogen replacement therapy and cognitive function in older women. JAMA 269:2637-2641, 1993.
22. Sherwin BB: Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345-357, 1988.
23. Kampen DL, Sherwin BB: Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83:979-983, 1994.
24. Valagussa P, Moliterni A, Zambetti M, et al: Long-term sequelae from adjuvant chemotherapy. Recent Results Cancer Res 127:247-255, 1993.
25. Tuxen MK, Hansen SW: Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 20:191-214, 1994.
26. Saykin AJ, Ahles TA: The Meyers article reviewed. Oncology 14:81-85, 2000.